Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-001074
Filing Date
2025-02-26
Accepted
2025-02-26 07:30:48
Documents
2
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_022625.htm 6-K 6032
2 PRESS RELEASE exh_991.htm EX-99.1 12977
  Complete submission text file 0001171843-25-001074.txt   20217
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
Quantum Biopharma Ltd. (Filer) CIK: 0001771885 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 25666160
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)